Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Key facts
- Who runs it
- Penn State University
- Where
- Boston and State College, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- People taking part
- 1,050 people, planned
- Started
- 3 Apr 2024
- Expected to end
- May 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- READI-SET GO UB-CAM delirium screening into EHR
- Record updated
- 20 February 2026
Who can take part
- Age
- 70 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- General medicine (hospitalist) service
- Age 70 or older
- Expected hospital length of stay of 3 or more days
Who cannot take part
- Inability to communicate adequately in English
- Admitted for terminal care
Where in United States
- Beth Israel Deaconness Medical CenterBoston, United StatesContact: Edward Marcantonio, MDTaking people
- Mount Nittany Medical CenterState College, United StatesContact: Donna Fick, PhDTaking people
About the trial
What the trial wants to find out
The goal of this step-wedge trial is to test the implementation of daily nurse screening for delirium in routine care and its impact on outcomes and complications in hospitalized older adults admitted to 6 general medicine/surgery units at 3 hospitals in Pennsylvania and Massachusetts.
Read full original descriptionShow less
The main question[s] it aims to answer are:
* 1. To test the fidelity, accuracy, and durability of implementing daily nurse screening for delirium using the UB-CAM in routine care. * 2. To evaluate the impact of UB-CAM delirium screening on patient and care partner centered outcomes assessed at one month follow-up interviews 3. To evaluate the impact of UB-CAM screening on rates of delirium complications (falls, pressure injury, aspiration) and adverse delirium management (psychoactive medication use, restraint use).
Participants (patients) will be assessed for delirium on study days 1, 2 and 3 (or until hospital discharge) and will be asked basic demographics. These patients will be contacted by phone 1 month after enrollment to collect information about inpatient facility use and to administer the Delirium Burden Patient Scale.
Participants (care partners) will be interviewed at the patient's discharge to complete the Alzheimer's Disease-8 scale. These care partners will be contacted by phone 1 month after enrollment to complete the Delirium Burden Caregiver Scale and to complete a Qualitative Interview which includes questions about communication and collaboration.
The 2 groups in the trial
- Readi Set Go Patient Oriented SampleTreatment being tested
Hospitalized older adults at risk of developing delirium providing informed consent will have the UB-CAM integrated into the electronic health record and RSDA delirium assessments.
Treatment: READI-SET GO UB-CAM delirium screening into EHR
- Readi Set Go Administrative SampleTreatment being tested
All patient admitted to the study wards for the duration of the study will have the UB-CAM integrated into the electronic health record
Treatment: READI-SET GO UB-CAM delirium screening into EHR
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- READI-SET-GO:Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation to Create Gero Friendly Organizations
- Record updated
- 20 February 2026